Drug Profile
RD 65071
Alternative Names: RD6-5071Latest Information Update: 22 Jun 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antivirals
- Mechanism of Action Protein kinase C inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 22 Jun 2001 No-Development-Reported for HIV-1 infections in Japan (Unknown route)
- 06 Nov 1998 New profile
- 06 Nov 1998 Preclinical development for HIV-1 infections in Japan (Unknown route)